The global weight-loss drug market, once dominated by Novo Nordisk, is undergoing a dramatic transformation. On Friday, the Danish pharmaceutical giant announced it would replace its long-serving chief executive, Lars Fruergaard Jorgensen, as the company faces mounting pressure from rivals and a sharp slide in its stock value. Novo’s shares…
Cox Communications has been a potential takeover target for years. But despite several attempts from multiple suitors, the company…
Thursday saw dramatic variations in the parallel exchange rate of the US dollar in Bolivia, with the informal currency market…
There are better ways to invest in AI infrastructure than CoreWeave Inc (NASDAQ: CRWV), says Ben Reitzes. He’s a…
President Donald Trump’s affinity for grand economic agreements is well-documented, rivaled perhaps only by his preference for low gasoline…
A wave of caution swept across Asian trading floors for the second consecutive day on Friday, as investors, finding…
Japan witnessed record foreign inflows into its equities and long-term bonds in April, as global investors reacted to US…
European equity markets, initially poised for a subdued start on Friday, found upward momentum as the trading session commenced,…
In an era where the “grindset” ethos—marked by punishingly early wake-ups, ice baths, and unwavering adherence to corporate norms—has…